And the US does not particularly need to urgently aim for ~$10-$15 as in many other affluent nations. This is a mistake commonly made by those griping about ins

And the US does not particularly need to urgently aim for ~$10-$15 as in many other affluent nations. This is a mistake commonly made by those griping about insulin prices, they expect that somehow magically we should just warp to $12 insulin pricing. That desire for step-skipping is never going to happen, that's a great way to never get anywhere. The reality of the giant mess of a healthcare system the US has means it can't work that way, and thinking otherwise is pure fantasy. Instead, $30-$40 would do just fine compared to where we're coming from, it would be tremendous progress. Once we get there, we can target ways to reduce it further to try to get closer to in-line with other nations. As you note, this improvement is welcome, and we should then focus on going after the next step-forward improvement.